Quantitative EEG in schizophrenic patients before and during pharmacotherapy

Neuropsychobiology

Volumn 41, Issue 3, 2000, Pages 166-170

  Begić, Dražen ^a   Hotujac, Ljubomir ^a   Jokić Begić, Nataša ^a  

^a KBC Zagreb   (Croatia)

Author keywords

Drug free patients; EEG; Neuroleptics; Schizophrenia

Indexed keywords

FLUPHENAZINE; HALOPERIDOL;

ADULT; ALPHA RHYTHM; ARTICLE; BETA RHYTHM; CLINICAL ARTICLE; DELTA RHYTHM; ELECTROENCEPHALOGRAM; FEMALE; FOURIER TRANSFORMATION; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; THETA RHYTHM;

EID: 0034020880     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026650     Document Type: Article

References (35)

1. Merrin EL, Floyd TC: Negative symptoms and EEG alpha in schizophrenia: A replication. Schizophr Res 1996;19:151-161.
2. Sponheim SR, Clementz BA, Iacono WG, Boiser M: Resting EEG in first epizode and chronic schizophrenia, Psychophxsiology 1994;31:37-43.
3. Miyauchi T, Tanaka K, Higamoto H, Miura T, Kishimoto H: Computerized EEG in schizophrenic patients, Biol Psychiatry 1990;28:488-494.
4. Koukkou M, Michel CM, Tremel E: FFT dipole sources and schizophrenic symptomatology. Brain Topogr 1991;3:466-467.
5. Gambini O, Colomho C, Macciardi F, Loccatelli M, Calabrese G, Sacchetti E, Scarone S: EFG power spectrum profile and structural CNS characteristics in schizophrenia. Biol Psychiatry 1990;27:1331-1334.
6. John ER, Prichep LS, Alper KR, Mas FG, Cancro R, Easton P, Sverdlov L: Quantitative electrophysiological characteristics and suhtyping of schizophrenia. Biol Psychiatry 1994;36: 801-826.
7. Miller A: Schizophrenia as a progressive disorder: Relations to EEG, CT, neuropathological and other evidence. Prog Neurobiol 1989;33: 17-44.
8. Morstyn R, Duffy FH, McCarley RW: Altered topography of EEG spectral conlent in schizophrenia. Electroencephalogr Clin Neurophysiol 1983;56:263-271.
9. Omori M, Koshino Y, Murata T, Murata I. Nishio M, Sakamoto K, Horie T, Isaki K: Quantitative EEG in never-treated schizophrenic patients, Biol Psychiatry 1995;38:303-309.
10. Merlo MCG, Kleinlogel H, Koukkou M: Differences in lhe EEG profiles of early and late responders to antipsychotic treatment in first-episode, drug-naive psychotic patients. Schizophr Res 1998;30:221-228.
11. Westphal KP, Grozinger B, Becker W, Dickmann V, Scherb W, Reess J, Leibing U, Kornbucher HH: Spectral analysis of EEG during self-paced movements: Differences between untreated schizophrenics and normal controls. Biol Psychiatry 1992;31:1020-1037.
12. Nagase Y, Okubo Y, Matsuura M, Kojima T, Toru M: EEG coherence in unmedieated schizophrenic patients. Topographical study of predominantly never medicated cases. Biol Psychiatry 1992;32:1028-1034.
13. Small JG, Milstein V, Small IF, Miller MJ, Kellams JJ, Corsaro CJ: Computerized EEG profiles ol haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia. Clin Electroencephalogr 1987;18:124-135.
14. Galderisi S, Mucci A, Mignone ML, Maj M, Kemali D: CEEG mapping in drug-free schizophrenics. Differences from healthy subjects and changes induced by haloperidol treatment. Schizophr Res 1992;6:15-24.
15. Nagase Y, Okubo Y, Toru M: Electroencephalography in schizophrenic patients: Comparison between neuroleptic-naive state and after treatment. Biol Psychiatry 1996;40:452-456.
16. American Psychiatric Association: Diagnostic Criteria from DSM-IV. Washington, American Psychiatric Association, 1994.
17. Overall J, Gorham D: Brief Psychiatric Rating Scale, Psychol Rep 1962;10:799-812.
18. Toru M: Pharmacology of Schizophrenics. Tokyo, Chugai Press, 1983.
19. Chatrian GE, Lectich E, Nelson PA: Modified nomenclature for the '10%' electrode system. J Clin Neurophvsiol 1988;5:183-186.
20. Roubicek J, Major I: EEG profile and behavioral changes after a single dose of clozapine in normals and schizophrenics. Biol Psychiatry 1977;12:611-633.
21. Kemali D, Galderisi S, Maj M: Computerized EEG topography findings in schizophrenic patients before and after haloperidol treatment. Int J Psychophvsiol 1992;13:283-290.
22. Saletu B, Küfferle B, Anderer P: EEC-brain mapping in schizophrenics with predominantly positive and negative symptoms. Comparative studies with remoxipride/haloperidol. Eur Neuropsychopharmacol 1990;1:27-36.
23. Galdcrisi S, Maj M, Mucci A, Bucci P, Kemali D: QEECi Alpha 1 changes after a single dose of high-potency neuroleptics as a predictor of short-term response to treatment in schizophrenic patients. Biol Psychiatry 1994;35:367-374.
24. Saletu B, Küfferle G, Grünberger J, Foldes P, Topitz A, Anderer P: Clinical, EEG mapping and psychometric studies in negative schizophrenia: Comparative trials with amisulpride and fluphenazine. Neuropsychobiology 1994; 29:125-135.
25. Schellenberg R, Milch W, Schwarz A, Schober F, Dimpfel W: Quantitative EEG and BPRS data following haldol-decanoate administration in schizophrenics. Int Clin Psychopharmacol 1994;9:17-24.
26. Buchsbaum MS, Haier RJ: Functional and anatomical brain imaging: Impact on schizophrenia research. Schizophr Bull 1987;13:115-132.
27. Gattaz WF, Mayor S, Ziegler P, Platz M, Gasser T: Hypofrontality on topographic EEG in schizophrenia. Correlations with neuropsychological and psychopathological parameters. Eur Arch Psychiatry Clin Neurosci 1992;241:328-332.
28. Andreasen NC Rczai K, Allinger R: Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon-133 single photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 1992;49:943-958.
29. Wolkin A, Sanfilipo M, Wolf AP: Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatry 1992;49: 959-965.
30. Kemali D, Galderisi S, Maj M: EEG correlates of clinical heterogeneity of schizophrenia; in Giannitrapani D, Murri L (eds): The EEG of Mental Activities. Basel, Karger, 1988.
31. Morihisa JM, Duffy FH: Focal cortical arousal in the schizophrenias; in Duffy FH (ed): Topographic Mapping of Brain Electrical Activity. Stoneham, Butterworth, 1988.
32. Alper K: Quantitative EEG and evoked potentials in adult psychiatry; in Panksepp J (ed): Advances in Biological Psychiatry. Greenwich, JAI Press, 1995.
33. Ulrich G, Müller-Ocrlinghausen B, Gaebel W: Changes in the topographical distribution of absolute alpha-power in the resting EEG of schizophrenic inpatients under neuroleptic medication. A responder-non-responder comparison. Pharmacopsychiatry 1986;19:220-221.
34. Buchsbaum MS, Potkin SG, Siegel BV Jr, Katz M, Gottschalk LA, Gulasekaram B, Marshall JF, Lottenburg S, Teng CY, Abel L, Plon L, Bunncy WE Jr: Slriatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry 1992;49:966-974.
35. Alper K, Günther W, Prichep LS, John ER, Brodie J: Correlation of qEEG with PET in schizophrenia. Neuropsychobiology 1998;38: 50-56.